Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aiko Biotechnology
AddedFeb 18, 2024
UpdatedJun 18, 2026
Aiko Biotechnology

Aiko Biotechnology

Pre-Seed

AIKO Biotech: Innovating pain treatment and reducing opioid side-effects with novel compounds.

HQ
Portland, ME, US
Founded
2006
Overview
Compare
Fundraising
Employees

Aiko Biotechnology is a startup based in Portland, ME, dedicated to discovering and validating novel compounds for pain treatment and mitigating side effects associated with opioid use, such as gastrointestinal dysfunction, addiction, and abuse. The company focuses on innovative solutions to improve patient outcomes in pain management.

Aiko Biotechnology has made significant strides in the biotech industry by developing groundbreaking treatments that address critical issues in opioid therapy. Their work has the potential to transform pain management practices and reduce the societal impact of opioid-related complications.

Aiko Biotechnology - Similar Companies

Akelos logo

Akelos

akelosinc.com

EicOsis logo

EicOsis

eicosis.com

Latigo Biotherapeutics logo

Latigo Biotherapeutics

latigobio.com

Concentric Analgesics logo

Concentric Analgesics

Aibios logo

Aibios

aibios.com

Isosceles Pharmaceuticals logo

Isosceles Pharmaceuticals

Aether Therapeutics logo

Aether Therapeutics

Aponia Laboratories logo

Aponia Laboratories

Phoenix PharmaLabs logo

Phoenix PharmaLabs

Trigemina logo

Trigemina

Bond Biosciences logo

Bond Biosciences

bond.bio

Amalgent Therapeutics logo

Amalgent Therapeutics

amalgent.com

BioIntervene logo

BioIntervene

Solace Pharmaceuticals logo

Solace Pharmaceuticals

Pacira BioSciences logo

Pacira BioSciences

pacira.com

Aiko Biotechnology - Quick Facts

Who are Aiko Biotechnology's competitors?

Companies similar to Aiko Biotechnology include Akelos, EicOsis, Latigo Biotherapeutics and Concentric Analgesics.

When was Aiko Biotechnology founded?

Aiko Biotechnology was founded in 2006.

Where is Aiko Biotechnology's headquarters located?

Aiko Biotechnology's headquarters is located in Portland, ME, US.

When was Aiko Biotechnology's last funding round?

Aiko Biotechnology's most recent funding round was for $850k (USD) in November 2009.

How much has Aiko Biotechnology raised to-date?

As of Nov 5, 2009, Aiko Biotechnology has raised a total of $850k (USD).

How many employees does Aiko Biotechnology have?

Aiko Biotechnology has 6 employees as of Feb 5, 2024.

Aiko Biotechnology - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Drug Development
  • Pain Treatment
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified